Tci Wealth Advisors, Inc. Vascular Biogenics Ltd. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 17, 2019	SELL	$0.6 - $1.72 $240 - $688	-400 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$1.55 - $2.17 $465 - $651	300 Added 300.0%	400 $1,000
Q2 2018 Jul 27, 2018	SELL	$2.05 - $3.0 $819 - $1,200	-400 Reduced 80.0%	100 $0
Q1 2018 Apr 30, 2018	SELL	$2.27 - $8.5 $681 - $2,550	-300 Reduced 37.5%	500 $1,000
Q4 2017 Feb 01, 2018	BUY	$5.65 - $9.0 $4,520 - $7,200	800	800 $6,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.